Stryker to buy back up to $750m in shares
This article was originally published in Clinica
Executive Summary
Shares in Stryker reached an all-time high for 2009 when it announced its board of directors gave the go-ahead for the company to repurchase up to $750m of its common stock. The orthopaedics firm saw its share price reach a peak $52.62 on December 3, before closing at $51.90.